The Story Behind the Discovery

When Pfizer-BioNTech announced 90% efficacy for their COVID-19 vaccine on November 9, 2020, and Moderna followed a week later with 94.5%, it felt like a miracle. The fastest vaccine in history before 2020 — the mumps vaccine — had taken four years. These took less than a year. But the real story behind this speed wasn’t an emergency shortcut. It was 30 years of research that had been repeatedly rejected for funding, considered too speculative for mainstream science, and pursued by a small number of determined scientists who simply refused to stop.

What the Science Actually Shows

Messenger RNA — mRNA — is a molecule that carries genetic instructions from DNA to the cell’s protein-making machinery. The concept behind an mRNA vaccine is beautifully simple: instead of injecting a weakened or killed pathogen, you inject molecular instructions telling your own cells to temporarily make a specific protein from the pathogen — in COVID-19’s case, the spike protein on the virus’s surface. Your immune system sees this spike protein, recognises it as foreign, mounts a response, and builds immunological memory. If you later encounter the real virus, you’re already prepared.

Why This Changes Everything

The problem was that injecting synthetic mRNA into the body triggered a violent immune reaction that destroyed the mRNA before it could do anything useful. The solution came from Katalin Karikó, a Hungarian-American biochemist at the University of Pennsylvania, and her colleague Drew Weissman. In a 2005 paper that was initially rejected by multiple top journals, they showed that by chemically modifying one of the nucleosides — the building blocks of mRNA — they could prevent the immune system from attacking it. This was the breakthrough that made practical mRNA vaccines possible.

The Bigger Picture

Karikó’s reward for this discovery was to be demoted by her university, which considered her research commercially unviable. It took Moderna and BioNTech — two comparatively small biotech companies — to bet heavily on mRNA technology, investing billions in developing delivery systems and manufacturing processes. When SARS-CoV-2 emerged in late 2019 and its spike protein sequence was published in January 2020, Moderna had a vaccine candidate designed in 48 hours. The platform existed. They simply loaded new instructions.

What Comes Next

The clinical trials were the largest in vaccine history, enrolling over 70,000 people each. The results confirmed the lab predictions. By 2024, the mRNA platform was being used to develop vaccines for flu, RSV, HIV, and personalised cancer treatments — where vaccines are designed to target the specific mutations in an individual patient’s tumour. Katalin Karikó received the 2023 Nobel Prize in Physiology or Medicine alongside Drew Weissman — vindication that arrived 18 years after a paper nobody wanted to publish changed medicine forever. For students, this represents exactly the kind of event that defines a generation’s scientific education. Future textbooks will describe this development as a turning point. But it is worth remembering that what looks clean and inevitable in a textbook was, in reality, the product of years of uncertainty, failed experiments, funding struggles, and the kind of stubbornness that characterises the best scientists. Progress in science rarely looks the way it does in retrospect.

Sources: Peer-reviewed journals, international scientific institutions. Image: Wikimedia Commons — Public Domain.
Image: The mRNA Vaccine: 30 Years of Ignored Science That Saved Millions — Wikimedia Commons public domain